Products
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Qingdao Central Hospital
🇨🇳
China
Country
🇨🇳
China
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab
Phase 2
Recruiting
Conditions
Pulmonary Fibrosis
Interventions
Drug: Dexamethasone
Drug: Bevacizumab
Subscribe
First Posted Date
2013-08-07
Last Posted Date
2023-03-29
Lead Sponsor
Qingdao Central Hospital
Target Recruit Count
30
Registration Number
NCT01917877
Locations
🇨🇳
Qingdao Central Hospital, Qingdao, Shandong, China
Subscribe
Prev
1
2
3
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy